Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization.
about
Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457TLive-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent DeliveryHybrid sequencing approach applied to human fecal metagenomic clone libraries revealed clones with potential biotechnological applicationsCloning of the dapB gene, encoding dihydrodipicolinate reductase, from Mycobacterium tuberculosisDNA modification and functional delivery into human cells using Escherichia coli DH10B.New vaccine strategies against enterotoxigenic Escherichia coli. I: DNA vaccines against the CFA/I fimbrial adhesin.Pathogenicity and immunogenicity of a Listeria monocytogenes strain that requires D-alanine for growth.The delicate balance in genetically engineering live vaccines.Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8(+) T cells and antiviral protective immunityTowards a synthetic chloroplast.A novel anti-virulence gene revealed by proteomic analysis in Shigella flexneri 2a.Targeting cattle-borne zoonoses and cattle pathogens using a novel trypanosomatid-based delivery systemYersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigen.Intracellular bacteria as targets and carriers for vaccination.Bacteria-mediated transfer of eukaryotic expression plasmids into mammalian host cells.Novel cancer vaccine based on genes of Salmonella pathogenicity island 2.In vitro and in vivo characterization of DNA delivery using recombinant Lactococcus lactis expressing a mutated form of L. monocytogenes Internalin A.Spinning molecular immunology into successful immunotherapy.Live bacterial vaccines--a review and identification of potential hazards.Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine.Microorganisms and cancer: quest for a therapy.Live bacterial vaccine vectors: an overview.Virulence plasmid instability in Shigella flexneri 2a is induced by virulence gene expressionGeneration of influenza virus from avian cells infected by Salmonella carrying the viral genomeBiosynthesis of diaminopimelate, the precursor of lysine and a component of peptidoglycan, is an essential function of Mycobacterium smegmatis.Bacteria-mediated DNA transfer in gene therapy and vaccination.Orally delivered malaria vaccines: not too hard to swallow.DNA vaccines for poultry: the jump from theory to practice.Genetic alteration of Mycobacterium smegmatis to improve mycobacterium-mediated transfer of plasmid DNA into mammalian cells and DNA immunization.Turning self-destructing Salmonella into a universal DNA vaccine delivery platform.Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet?Self-adjuvanting bacterial vectors expressing pre-erythrocytic antigens induce sterile protection against malariaSalmonella enterica serovar Typhi live vector vaccines finally come of ageInduction of protective cellular immunity against Mycobacterium tuberculosis by recombinant attenuated self-destructing Listeria monocytogenes strains harboring eukaryotic expression plasmids for antigen 85 complex and MPB/MPT51Engineering the perfect (bacterial) cancer therapyA one-plasmid system to generate influenza virus in cultured chicken cells for potential use in influenza vaccine.Bacteria as vectors for gene therapy of cancer.Treating cancer with infection: a review on bacterial cancer therapy.Targeting of MYCN by means of DNA vaccination is effective against neuroblastoma in mice.Use of lambda phage S and R gene products in an inducible lysis system for Vibrio cholerae- and Salmonella enterica serovar typhimurium-based DNA vaccine delivery systems.
P2860
Q22065494-6B384638-06A6-449B-BDAD-9D79588B16B2Q28084076-FAFDFC74-2DA9-4D99-B7E4-802C06DEBD09Q28484452-BD539CFD-E5A8-4A57-9FFA-C79E77A757FDQ28486459-63F374CF-A9A8-463E-BD3E-19F6F43BE397Q30918840-EB23F82D-2B34-4555-A45B-E2D0EE1F5C21Q33646678-8C88CC28-99F9-4849-9A13-86FA9F8F5237Q33757296-B240987D-C264-4DA9-A920-FCB119270C36Q33801051-47084DAD-7F1D-49EE-98AD-077005B6F5B7Q33846454-C5DD161C-DFB1-4AE8-9A09-234516AB78CEQ33886250-5B3C9A82-AE76-4EE4-9F65-751C9EFDF66FQ33997958-3BFE6E0E-4F74-4DC7-8793-A3A5413588EBQ34064231-9C30DB30-1088-4346-AC0F-8954E5595255Q34120666-4E6C3416-DD02-4483-9B52-8BD69C6BB4ACQ34280918-3A9C3C92-6338-4D75-B176-925375F9710FQ34280924-23DA48A9-75D9-48E7-B640-969FE29C32B6Q34357503-38DD4D6C-3148-4157-82E8-0EE84D7DC19FQ34518201-A054ABC6-A68F-4BEA-A012-79B163A57A28Q34632056-5CEF5819-5AA6-4EF3-AEA1-741B21EAAB35Q34974711-F07A708C-5E0D-4DBB-8BCE-D307EB125920Q34975686-3B0A1D36-19A9-458E-9C2C-50339DFF2E81Q34983790-4570AEE3-FE1A-48E3-B0B0-447BC7741B77Q35068970-4C042B90-374F-4ED3-86EC-550547125588Q35554877-03B47CE3-B559-4A29-B58C-931E3E6A3E59Q35572130-8D37FF28-E299-4CED-8BC6-59529922D0B6Q35616744-CC3D0824-6BF9-4351-8F61-A489D4BA64E5Q35681498-414F0B48-D567-4B01-85BB-3993D66DFC8CQ35907014-DEED06EF-C202-46DB-8436-33E5C8FE2CABQ36066247-17D9A8F8-BF41-4DA4-B783-0B69470E47C9Q36097286-98565019-CC07-4406-B6F9-85552917A782Q36436730-CCF4BF13-CBBA-4411-B828-FC0BD38541A2Q36837160-F2960922-0FDF-4BE8-80D3-967F5882F767Q36981626-7FDAFCDF-F5EF-4CF5-96AE-7167A995CF36Q37106127-198E723F-67BC-45FA-B703-AC9D2B08DB69Q37117196-76550F22-A1CA-489A-B8BE-265FEAA70CDDQ37131536-D111CE88-FACB-4A38-8681-59FE9E58002AQ37333919-0206F9E6-AED4-4229-87F4-D7D7395ABBD2Q37862087-F27F7999-880D-4FA7-84BD-B39345847CF6Q38473938-3C95685A-74B1-4BBA-8788-FCAE2C5E9320Q38863894-52689941-E830-4B14-BC8A-F0360F0D5B45Q39514280-89FECB04-B8B5-46F2-A4DA-8BE703984C81
P2860
Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization.
description
1995 nî lūn-bûn
@nan
1995 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization.
@ast
Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization.
@en
Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization.
@nl
type
label
Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization.
@ast
Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization.
@en
Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization.
@nl
prefLabel
Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization.
@ast
Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization.
@en
Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization.
@nl
P2093
P1433
P1476
Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization.
@en
P2093
Branstrom AA
Sizemore DR
P304
P356
10.1126/SCIENCE.270.5234.299
P407
P577
1995-10-01T00:00:00Z